Skip to main content

Maria Martell Pérez-Alcalde

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Maria Martell Pérez-Alcalde

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

Projects

Estudio longitudinal de la expresión génica diferencial de la alteración vascular esplácnica en el modelo experimental de hipertensión portal de rata. Papel de los mecanismos de angiogénesis

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández, Maria Nieves Martell Pérez-Alcalde
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 83490
Reference: SAF2006-03714
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Efecto de la variabilidad genética en la región NS3 del Virus de la hepatitis C (VHC) sobre maduración y presentación de proteínas recombinantes aislado-específicas de células dendríticas autólogas.

IP: -
Collaborators: Silvia Sauleda Oliveras, Josep Quer Sivila, Maria Nieves Martell Pérez-Alcalde, Juan Ignacio Esteban Mur
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 164600
Reference: SAF2003-08724
Duration: 15/12/2003 - 15/12/2006

Ministerio de Ciencia

Conservación de la estructura del rna y accesibilidad a la rnasa p en dos motivos del rna genómico del virus de la hepatitis c para una nueva terapia antiviral.

IP: -
Collaborators: Maria Nieves Martell Pérez-Alcalde, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 72722.46
Reference: 01/1351
Duration: 17/07/2001 - 31/12/2003

Related news

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Bajaña Mindiolaza, Ivan

Bajaña Mindiolaza, Ivan

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Torres Barbosa, Asbleidy Carolina

Torres Barbosa, Asbleidy Carolina

Research technician
Childhood Cancer and Blood Disorders
Read more
Guerrero Flores, Javier

Guerrero Flores, Javier

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Victor Guerra Ruiz

Victor Guerra Ruiz

Research technician
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.